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Allied Industry Approaches to Alter Intramuscular
Fat Content and Composition in Beef Animals
MICHAEL V. DODSON, ZHIHUA JIANG, JIE CHEN, GARY J. HAUSMAN, LE LUO GUAN, JAN NOVAKOFSKI,
DAVID P. THOMPSON, CAROL L. LORENZEN, MELINDA E. FERNYHOUGH, PRIYA S. MIR, AND JAMES M. REECY
ABSTRACT: Biochemical and biophysical research tools are used to define the developmental dynamics of numer-
ous cell lineages from a variety of tissues relevant to meat quality. With respect to the adipose cell lineage, much of
our present understanding of adipogenesis and lipid metabolism was initially determined through the use of these
methods, even though the in vitro or molecular environments are far removed from the tissues of meat animals.
This concise review focuses on recent cellular andmolecular biology-related research with adipocytes, and how the
research might be extended to the endpoint of altering red meat quality. Moreover, economic and policy impacts
of such in animal production regimens is discussed. These issues are important, not only with respect to palata-
bility, but also to offer enhanced health benefits to the consumer by altering content of bioactive components in
adipocytes.
Keywords: adipocytes, meat quality, review
Introduction
Abalanced diet should contain safe red meat products (Sofos2008; Vandendriessche 2008), as lean meat provides a vari-
ety of nutrients required for a healthy lifestyle (Scho¨nfeldt and
Gibson 2008; Wood and others 2008). However, the fat (adipose tis-
sue) component of redmeat still draws negative attention (Web and
O’Neill 2008;Wood and others 2008). Despite the positive contribu-
tion of adipose tissue to the appearance, texture, flavor, firmness,
caloric value, and shelf-life of red meat products (Dransfield 2008;
Ngapo and Gariepy 2008; Web and O’Neill 2008; Wood and oth-
ers 2008), excess adipose tissue (Wood and others 2008), and meat
products containing saturated fatty acids (Wood and others 2008)
are considered unhealthy (Scho¨nfeldt and Gibson 2008; Web and
O’Neill 2008; Hausman and others 2009).
It is apparent that scientists have become increasingly effec-
tive in their in vitro identification of potential regulatory agents
that could significantly impact the adiposity of red meat animals
(Mersmann 1998a; Hausman and others 2008b, 2009). Studies us-
ing cellular methods have documented regulators of adipocyte cell
cycle transition (Hausman and others 2008b, 2009), toxins (Haus-
man and others 2008b), cellular and molecular markers of adipo-
genesis and lipid metabolism (Kokta and others 2004; Fernyhough
and others 2007; Hausman and others 2008b), metabolic modifiers
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(Hausman 1989; Peterla and Scanes 1990; Mersmann 1998b;
Gondret and others 2008; Hausman and others 2008b, 2009), and
potential secretion of endocrine and paracrine regulators that
might regulate a variety of different tissues in vivo (Jacobi and oth-
ers 2006; Gabler and Spurlock 2008; Hausman and others 2008b).
Molecular methods have yielded a variety of linkages between spe-
cific genes and numerous meat quality characteristics such as fat-
ness (Oishi and others 2000; Dekkers 2004; Michal and others 2006;
Sasaki and others 2006; Hausman and others 2007, 2008b, 2009;
Hollung and others 2007; Lee and others 2007; Taniguchi and others
2008a, 2008b, 2008c). The question remains though, should bench
scientists identify a viablemarbling agent thatmodifies cellular sig-
naling sufficiently to alter fatness of a meat animal, would the pub-
lic ever see the results applied to meat production?
Red meat animal producers in the United States are not allowed
to treat animals destined for human consumption with chemical
agents that are deemed unsafe, except in the need of clinical in-
tervention. Rompum (Xylazine), for example, is a carcinogen that
is commonly used in clinical conditions, even in “organic” cat-
tle. Moreover, a lengthy testing/review process is involved prior to
the approval of any compound to enhance production (FDA 2006).
More rigorous regulations (to the point of complete restriction)
are in effect elsewhere in the world and will potentially become
more prohibitive (Verbeke and others 1999; Higgs 2000; Higgins
2004; Croney and Millman 2007; Thompson and others 2007). At
the same time, a proportion of consumers, producers, and scien-
tists have voiced their belief that meat from animals treated with
pharmaceuticals or fed feed treatedwith pesticides is less “healthy”
to eat. In this environment, then, will any knowledge gained by cel-
lular or molecular experimentation be applicable for the modula-
tion of any aspect of meat quality? For example, if the research goal
of a cellular or molecular meat scientist is to optimize adipocyte
growth and development in specific adipose depots of red meat
animals, how does one apply research observations to an effective
(and acceptable) endpoint to alter red meat quality in the whole
animal? Will whole animal production alterations be the only ac-
cepted method to attempt to manipulate such processes (Mir and
others 2008)? The focus of this concise review is to demonstrate
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endpoints of such research efforts and to extend our previous re-
view (Hausman and others 2009).
Intramuscular fat
At the cellular level, fattening of meat animals is a function of
adipocyte size and numbers (Hood and Allen 1973; Robelin 1981;
Hood 1982; Cianzio and others 1985; Gondret and Lebret 2002;
Yang and others 2006) and distribution throughout the animal in a
depot-specific manner (Hausman and others 2009) or in a specific
muscle (Gondret and Lebret 2002; Albrecht and others 2006; Yang
and others 2006). A recent review thoroughly discusses aspects of
adipogenesis and lipid metabolism (Hausman and others 2009).
Meat tenderness andmarbling endpoint
Marbling (intramuscular adipose tissue) has been shown to play
an important role in the eating quality and composition of meat
(Moloney and others 2001). While marbling may impact compo-
nents of tenderness its regulation varies tremendously both within
and across breeds of cattle (Albrecht and others 2006) and swine
(Hausman and others 2009) and is determined by a wide range of
factors such as genetics, husbandry (time of weaning, nutrition,
duration of grow-out, physical activity), and seasonal temperature
variations. Importantly, it has already been shown that marbling
can be positively or negatively affected by agents commonly ad-
ministered to cattle to promote growth rate and feed conversion ef-
ficiency, such as implants and β-agonists (Brandt and others 1996;
Gaylean 1997; Macken and others 2003; Sillence 2004). For exam-
ple, marbling effects have also been demonstrated for melanoge-
strol acetate, a progestin used to suppress estrus, when dosed
in-feed to steroid implanted finishing heifers (Macken and others
2003). Thus, the multivariate nature of the marbling process is un-
derscored by the numerous influencing factors that modulate it
(Devitt and Wilton 2001; Hausman and others 2007, 2008a; Tchko-
nia and others 2007). Furthermore, while there may be the poten-
tial to identify strategies to specifically enhance marbling content,
little is presently known as to how these regimens may alter subcu-
taneous or intermuscular fat.
Adipose tissue can have positive or negative economic impacts
on both beef and pork carcasses. In the United States, marketing
of beef is based on both USDA yield and quality grades with the
highest value given to carcasses with high-quality grades (more in-
tramuscular fat) and the lowest value to low yield grades (more
subcutaneous and internal fat). In addition, the USDA yield grade
also predicts the amount of intermuscular fat in the beef carcass.
Savell and Cross (1988) suggested that aminimum threshold for in-
tramuscular fat was approximately 3% for all livestock species to
ensure an acceptable eating experience. The 2005 Natl. Beef Qual-
ity Audit reported the average U.S. beef carcass has a USDA yield
grade of 2.9 and a quality grade of Select (Garcia and others 2008).
Three Natl. Beef Quality Audits have characterized the U.S. beef
population prior to 2005, and there has been very little fluctua-
tion in average USDA yield and quality grades. The USDA yield
grades reported were 3.2, 2.8, and 3.0 for 1991, 1995, and 2000, re-
spectively (Lorenzen and others 1993; Boleman and others 1998;
McKenna and others 2002). Smith and others (1987) reported a lin-
ear and hierarchical relationship between USDA quality grades in
beef and eating quality of the longissimusmuscle. Neely and others
(1998) examined 3 different beef muscles and found that the USDA
quality grade only affected consumer preference for top loin steaks
and that the amount of intramuscular fat may only be affective in
sorting beef cuts that contain the longissimus muscle. In contrast,
pork is marketed in the United States based on the percentage lean
and carcass weight. While pork carcass weight is influenced by adi-
pose tissue deposition, the main depot of concern is the subcuta-
neous depot. In fact, a study conducted on the U.S. pork revealed
that boneless loin chops were almost devoid of intramuscular fat
(Wright andothers 2005). Unlike beef, research shows thatmarbling
has very little effect on the eating quality of pork (Rincker and oth-
ers 2008) and that consumers prefer the appearance of pork chops
that are not heavily marbled (Brewer and others 2001).
The interface of the USDA and adipose tissue occurs in the
area of marketing and regulatory programs. Specifically, the Agri-
culture Marketing Service is responsible for developing and im-
plementing the USDA grades for beef and pork and reporting on
livestock and meat prices. The USDA has developed pork carcass
standards (USDA 1985) and beef quality and yield grades (USDA
1997) to segregate carcasses based on their expectedmeat yield and
palatability.
“OMICS” with adipogenesis or lipogenesis
Contemporary molecular techniques, both existent and on the
near horizon, offer multiple approaches to a more productive
understanding of adipogenesis and lipid metabolism. Genomic
analysis of quantitative trait loci (QTL) and single nucleotide poly-
morphism (SNP) quantify and explain the underlying basis of
genetic variation in populations, directly improving selection
strategies for fat associates traits. Transcriptomics (gene expres-
sion) studies improve understanding of the species-specific im-
portance of metabolic pathways and help identify additional
components of complex intracellular and extracellular regulatory
networks. Proteomic analysis helps to explain posttranscriptional
modulation and the resulting physiological regulation dynamics
downstream of expression. Thus, OMICS-based research may sug-
gest pharmaceutical or nutritional intervention and indirectly sup-
port selection decisions.
Pathway-based approaches to identify potential candidate
genes associated with fat deposition and composition for im-
proving meat quality. It is well known that many pathways
are involved in regulation of fat deposition, such as the mito-
chondrial biogenesis complex, the long chain fatty acids uptake
complex, the sauvagine/corticotropin-releasing factor/urotensin I
family and related families, the lipogenesis/lipolysis enzymes, and
even cholesterol homeostasis pathway (Daniels and others 2009;
Jiang and others 2009). Using aWagyu x Limousin F2 reference pop-
ulation, our studies have revealed that the corticotropin releasing
hormone (CRH; Wibowo and others 2007), fatty acid binding pro-
tein 4 (FABP4; Michal and others 2006), stearoyl-CoA desaturase
(SCD1; Jiang and others 2008), mitochondrial transcription factor
A (TFAM; Jiang and others 2005), urocotin 3 (UCN3; Jiang and oth-
ers 2006), and ubiquinol-cytochrome c reductase core protein I
(UQCRC1; Kunej and others 2007) are associated with beef mar-
bling scores.
Pathway analysis has also identified several candidate genes that
are associated with fatty acid composition. For example, stearoyl-
CoA desaturase (SCD1) is an iron-containing enzyme that cat-
alyzes a rate-limiting step in the synthesis of unsaturated fatty acids
(Miyazaki and Ntambi 2003). The principal product of SCD is oleic
acid that is formed by the desaturation of stearic acid. The ratio of
stearic acid to oleic acid has been implicated in the regulation of
cell growth and differentiation through its effects on cellmembrane
fluidity and signal transduction. Taniguchi and others identified a
nonsynonymous mutation in SCD1 of Japanese-Black cattle that
was associated with the saturation level of fatty acids and fat melt-
ing temperature (Taniguchi and others 2004). Similarly, the same
allele is associated with the saturation level in American Angus
cattle. Recently, Jiang and others (2008) identified additional SCD1
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alleles that were significantly associated with 6 fat deposition
and fatty acid composition traits in skeletal muscle. In particular,
high stearoyl-CoA desaturase activities/alleles were positively cor-
related with beef marbling scores and the amount of monounsat-
urated fatty acids and conjugated linoleic acid content, but were
negatively correlated with the amount of saturated fatty acids. Fur-
thermore, Zhang and others (2008) identified a nonsynonymous
mutation in the thioesterase domain of fatty acid synthase, which
was associated with decreased amounts of unsaturated fatty acids.
Similarly, a nonsynonymous mutation in myostatin is also associ-
ated with reduced levels of saturated fatty acids. Therefore, these
studies provide evidence that it is possible to produce beef with
high marbling, high amounts of monounsaturated fatty acids, and
conjugated linoleic acid content, butwith low amounts of saturated
fatty acids.
Although not a focal point of this article, it should be noted
that similar studies have been conducted with pigs. For exam-
ple, porcine adipose tissue is innervated by adrenergic nerve fibers
(Hausman and Richardson 1987). Trans-synaptic viral tracing tech-
niques have identified multisynaptic pathways that link adipose
tissue depots to the brain in the pig and other species. Transcrip-
tional profiling has also been used in pigs to determine subcu-
taneous adipose depot-specific pathways that respond to either
fasting (Lkhagvadorj and others 2008), feed restriction (Lkhag-
vadorj and others 2006), or response to melanocyte-stimulating
hormone (MSH) injection in prepubertal gilts. In response to
MSH injection, 5070 genes in adipose tissue were differentially
expressed. For example, lipoprotein lipase, fatty acid synthase,
aconitase-1, acetyl CoA synthase, leptin, and heat shock protein
70.2 genes were down regulated, whereas angiopoietin-like 4, pyru-
vate dehydrogenase kinase 4 isoform 1, uncoupling protein 3,
and insulin-like growth factor binding protein-3 were upregulated.
These results demonstrated that stimulation of MC4R markedly
and rapidly affected adipose tissue gene expression. Clearly, adjust-
ment of the environment with subsequent change in sympathetic
outflow to subcutaneous adipose tissue could be used to create the
desired nature and timing of adipose tissue deposition in specific
adipose depots.
The expression of mRNA for a number of regulatory and
metabolic genes has been examined in adipose tissue from grow-
ing pigs but most of these studies typically have examined the ex-
pression of 1 to 2 genes at a single age. Recently, adipocyte cell lines
isolated from different animals were used to demonstrate that adi-
pogenesis is controlled by species-specific mechanisms. For exam-
ple, beef-derived adipocytes showed different regulation pathways
than murine adipocytes (Fernyhough and others 2007; Taniguchi
and others 2008a, 2008b). Lipid-filled pig adipocytes physically ex-
truded lipid from the cell before they started to proliferate, whereas
beef-derived adipocytes, that symmetrically or asymmetrically di-
vide into daughter cells, do not expel cellular lipid (Fernyhough
and others 2005a, 2005b). Gene expression profiling of porcine
adipocytes showed that triacylglycerol hydrolase (TGH) expres-
sion was differentiation-dependent in porcine primary adipocytes
and that TGH played a role in fasting-induced lipolysis but not
hormone-stimulated lipolysis (Zhang and others 2008).
Transcriptome analysis of fat deposition and composition
of beef and pork meat. Depot-specific adipocytes may be in-
fluenced by many factors including feeding behavior, growth,
metabolism, and the development of puberty through the secre-
tion of leptin, several interleukins, and a number of other cytokines
(Barb and others 2006; Jacobi and others 2006; Trayhurn and oth-
ers 2006). Recent technological advances have made it feasible
to analyze the complete set of RNA transcripts (gene expression
and alternative splicing) produced in a tissue/cell at a given time
(Mortazavi and others 2008; Pan and others 2008). Microarray anal-
ysis of the bovine subcutaneous adipose depot revealed that hun-
dreds of genes were differently expressed between animals with low
and high backfat thicknesses (Taniguchi and others 2008c), which
suggests that the molecular mechanisms may vary during adipose
depot formation. Furthermore, many transcription factors, intra-
cellular signaling factors, and other regulatory factors are involved
in the differentiation and function of depot-specific adipocytes
(Farmer 2006; Rosen and MacDougald 2006; Prestwich and Mac-
Dougald 2007; Taniguchi and others 2008c). However, studies of the
influence of age, nutrition, and hormones on gene and protein ex-
pression in adipose tissue from red meat animals have been lim-
ited in regard to the number of genes and proteins examined and
the consideration of depot variation or influence (Fernyhough and
others 2007; Hausman and others 2009).
Gene expression/transcriptome profiling provides a dynamic
link between the genome, the proteome, and the tissue/cellular
phenotype (Basu and others 2009). This can lead to further insight
into the complex interplay of gene expression events involved in the
development of meat quality (Basu and others 2009). Furthermore,
the application of a functional proteomics approach to the identi-
fication of proteins associated with fat deposition and composition
in meat will contribute to a better understanding of the biological
processes that control adipose development and ultimately affect
meat quality (Basu and others 2009). Through the application of
functional genomic and proteomics tools, we will gain insight into
how genetic components regulate adipogenesis, how they respond
to environmental changes, andwhether these changes affect the fat
deposition and composition inmeat (Basu and others 2009). These
discoveries should allow us to establish better management sys-
tems to ensure the delivery of an optimal meat product that meets
the needs of the consumer.
Animal/human health industry
Recent advances in bovine genetics and cell biology, especially
aspects of the biology of the bovine adipocyte, have provided
many of the tools required for rational-based discovery programs
for beef marbling agents (Fernyhough and others 2007; Hausman
and others 2008a, 2008b). Discovery programs in humanmedicine,
especially those for obesity and diabetes, have developed other
useful technologies such as bioassays for the molecular pathways
involved in lipid and fatty acid processing (Spiegelman and Flier
1996; Horton 2002; Horton and others 2002; Bergen andMersmann
2005).
Fromadrug discovery perspective, alteringmarbling is a double-
edged sword. On the one hand, the complex cellular andmetabolic
regulation offers numerous potential targets for intervention to im-
prove marbling. On the other hand, the total systems physiolog-
ical complexity suggests that targeting single factors may not be
sufficient to favorably affect marbling. As such, pharmaceutical-
based approaches targeting the adipocyte represent only 1 poten-
tial strategy for improvingmarbling in cattle; new diets (containing
nutraceuticals, for example), genetics/breeding systems, vaccines,
and (perhaps) virtual screening (as a drug discovery tool) could
each offer alternative approaches (Kimand others 2003; Sellner and
others 2007). These approaches may pose fewer barriers to com-
mercialization, especially those related to food and environmental
safety. Identifying a pharmaceutical agent that meets all of the cri-
teria required for approval as a marbling agent will not be a trivial
exercise.
Is there a market rationale for the use of marbling agents
in beef production? Although not yet substantiated by a product,
Vol. 75, Nr. 1, 2010—JOURNAL OF FOOD SCIENCE R3
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the potential market opportunity for a marbling agent for use in
beef cattle can be estimated on the basis of historical price spreads
across meat grades (determined principally by marbling score).
Based on historical averages, a marbling agent that increased the
number of cattle graded as choice by only 5% could be worth tens
of millions of dollars. Cattle represent the largest economic op-
portunity for a marbling agent, but other livestock species, includ-
ing swine, sheep, and poultry represent potentially lucrative op-
portunities for active compounds, as current production practices
for all livestock are generally antagonistic to the marbling process
(Sillence 2004; Hausman and others 2008a). The potential value
of a marbling agent in the market place is supported by a broad
range of economic and demographic factors. Consider the bottom
line first. The Select/Choice price spreads for the U.S. beef—a di-
rect function of marbling—have ranged $6 to 12/100 weight since
2000, averaging $10/100 weight. Marketing programs such as Cer-
tified Angus Beef (CAB
R©
), which is based on marbling scores of
average Choice or higher, take advantage of this price spread.
The gap between the numbers of CAB
R©
cattle produced in the
United States compared with the market need has typically ranged
from 17% to 19% (Garcia and others 2008). This translates, roughly,
into an opportunity of about $80/head for the producer. Assum-
ing a 6:1 return, this could translate into a product that sells for
>$10/dose regimen. This would provide a substantial market op-
portunity by any standards. In 2008, however, price spreads de-
clined in response to global economic conditions; this highlights
a potential caveat for any product that promotes meat quality only.
Numerous other factors favor the potential marketability of a
marbling agent for beef cattle. Breeding programs have selected
for faster-growing and more energy-efficient animals at the cost
of marbling and tenderness (Hausman and others 2008b). Mod-
ern husbandry practices, especially in countries such as the United
States that use feedlots extensively, have reduced the grow-out pe-
riod to<24 mo in order to save feed, labor and time; cattle are thus
harvested prior to the late phase of fat deposition. In addition, since
the 1980s, beef production has expanded rapidly in the southern
hemisphere, including Brazil and Argentina, where grass fed pro-
duction accounts for >90% of the animals harvested. These ani-
mals are generally lessmarbled than cattle raised inNorth America,
most likely a function of not only genetics and diet, but also due to
the increased physical activity required of animals raised on pas-
ture. A marbling agent could reverse the impact of these trends on
meat quality.
Another emerging factor is the expanding use of growth-
promoting agents, especially the β-agonists, that has led to im-
provements in performance (feed conversion efficiency, average
daily gain) but has also led to less marbled and less tender cuts of
meat. These compounds act specifically by repartitioning energy
away from fat and toward lean muscle accretion (Sillence 2004).
Adoption of these agents has been driven recently by remarkable
increases in the price of corn and other feedstuffs, which now ac-
count for over 70% of the cost of raising beef in the U.S. finishing
lots. The tremendous economic advantage they provide is incen-
tive for continued and expanded use of these products. An agent
that reversed the effects that β-agonists have on marbling and ten-
derness, without negating the growth advantages, would likely be
well received by the market.
Indirect evidence for the concept that marbling in cattle can
be affected by exogenous agents has already been demonstrated,
based on observations that controlling levels of vitamin D and
retinoic acid in the diet can result in predictable changes in mar-
bling, and that marbling generally correlates in some fashion with
blood levels of these vitamins (Gorocica-Buenfil and others 2007a,
2007b). Correlations between marbling and homeostatic signaling
molecules that can be targeted by drugs, such as leptin (Bonnet and
others 2007; Cheong and others 2008) support the concept that se-
lective marbling agents might be identified. In the target animal
itself, the administration of melanogestrol acetate (MGA) in fin-
ishing heifers that are also implanted with anabolic steroids has
been shown to promote marbling (Macken and others 2003). How-
ever, marbling is not affected by MGA in heifers when adminis-
tered alone or in implanted or nonimplanted steers (Montgomery
and others 1992; Brandt and others 1996; Hendricks and others
1997).
Adipocytes hold the potential for synthesizing or serving as de-
pots for other health factors (conjugated linoleic acid, omega-3
fatty acids, and other health-promoting proteins and fatty acids).
These could be introduced by way of adipocytes through genetics,
diet, or pharmaceutical agents (Gillis and others 2004; Dhiman and
others 2005; Noci and others 2005; Bouattour and others 2008). The
concept of “healthy” beef would be appealing to many consumers,
especially those already willing to pay a premium for omega-3 en-
riched poultry and fish products.
What would it take to discover and develop a beef-marbling
agent? The strategy adopted will depend to some extent on
whether the approach to improve marbling is pharmaceutical-,
nutraceutical-, vaccine-, or genetics-based. Approaches to a phar-
maceutical could consist of high throughput targeted screening
against a key enzyme or receptor identified in basic studies that de-
lineate lipogenesis and adipogenesis in cattle (Hausman and oth-
ers 2008a, 2008b). Alternatively, candidate compounds could be
selected from agonist families already identified by human phar-
maceutical programs, such as those targeting diabetes or obesity,
in which fat metabolism or deposition are key endpoints. In this
case, the validity of the target, albeit in other species, would already
be established by RNA interference studies and pharmacology
(Sellner and others 2007). Ideally, the importance of the target
would also be consistent with data from genetics studies in beef
cattle suggesting a role for the target in intramuscular fat deposi-
tion (Kim and others 2003). With such background, in vivo proof-
of-concept studies in cattle (for example, treatment of cattle with
a peroxisome proliferator-activated receptor γ (PPARγ ) agonist or
compounds already shown to promote lipogenesis) could be com-
pleted in a short timeframe. Testing these compounds could be-
gin in vitro using a bovine adipocyte assay. This assay would be
designed to determine if the compound drives the expression of
key genes or activates key proteins in the adipocyte differentiation
pathway (Fernyhough and others 2007), and to gain early insights
into relative agonist activity. Early testing of these compounds for
metabolic stability would also be done, using bovine liver tissue or
hepatocytes. In general, compounds that are more stable to degra-
dationwould be favored over those that are rapidly degraded, espe-
cially at the early stages of concept testing. Compounds with lower
stability compared with metabolic degradation may be desired for
development, consistent with a short or zero-day withhold period,
if drug or active metabolite residues are an important issue for the
approach.
Candidate compounds that show adipogenic activity in the
bovine adipocyte assay could be tested in a secondary screen
or taken directly to cattle as the target species to define phar-
macokinetics (time course of activity) and pharmacodyamics (ef-
fective concentrations or doses). These could be evaluated using
marbling as the desired outcome or appropriate biomarkers within
the target species. The biomarkers selected to evaluate drug activ-
ity could include metabolites immediately downstream from the
target enzyme, perhaps measurable in a blood sample, or target
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gene expression levels in intramuscular fat deposits obtained from
skeletal muscle (Fernyhough and others 2007; Hausman and oth-
ers 2008a, 2008b). These studies would be designed principally to
test the concept that the drug is capable of driving intramuscular
fat deposition in the right direction and, secondarily, to identify a
safe dose for achieving that endpoint.
Once a chemical series is identifiedwith activity in the target ani-
mal, additional screening would likely be required using the bovine
adipocyte model on a large number of structural analogs against
the target to optimize the lead for potencywithin the chemical fam-
ily of the candidate compound. These studies would be coupled
with information obtained from in vitro and in vivo metabolism
studies toward identifying compounds that have suitablemetabolic
profiles (that is, short half-life or low tissue residues if the approach
requires dosing late in the finishing phase).
Definitive proof of concept testing in finishing cattle would in-
volve dosing finishing cattle, probably over several weeks initially,
and testing for significant increases in marbling score and intra-
muscular fat levels using a defined cut of meat (for example, 11th
rib eye) as well as other carcass quality indicators (% lean, shear
force, pH). It would also include measurement of key biomarkers.
Subsequent to establishing efficacy, target animal safety testing at
3× and 10× the projected use level for an injectable or an in-feed
agent, respectively, would be done, along with preliminary formu-
lation and large-scale production studies.
Postdiscovery drug development processes would not likely be
unique for a marbling-enhancing product. In addition to multi-
site testing for potential influences of breed, husbandry practices,
and potential interactions with other compounds typically used
by the target market, extensive testing for production/formulation
and safety, including target animal, human food, and environmen-
tal, would be required, as they are for any new compound that en-
ters the food chain. Regional differences in regulatory requirements
would clearly affect the development process, that is, performance
agents are not currently approvable/marketable in the European
Union.
What are the potential barriers to the successful discovery,
development, and introduction of ameat quality product? Two
general types of challenges would face such a product: barriers to
discovery and development, and barriers to market acceptance.
One barrier to discovery is the desired outcome. The link between
marbling and tenderness is not high (Haley 2006). One implica-
tion of this is that an intervention that increases marbling may not
achieve the desired outcome of also increasing tenderness. Raising
caloric content without a corresponding increase in eating qual-
ity couldwell be counterproductive. Alternatively, lipid content, per
se, is a very minor contributor to tenderness, so some component
of adipogenesis could be an excellent surrogate as a screen for the
physiology underlying improved tenderness. For example, the ma-
trix protease MT1-MMP plays an important role in enabling adi-
pogenesis (Chun and others 2006) and may reflect other protease
activities influencing tenderness. An equally important scientific
barrier to success is the current lack of a cost-effective surrogate
model for efficiently testing early-stage concepts. Factors govern-
ing fatty acid processing in rodents, rabbits, pigs, and even goats
differ substantially from cattle (Taniguchi and others 2008a). These
differences point out the value of validating a specific response in
lab animals as a surrogate for marbling. Species differences could
also limit the ability to leverage active molecules across target ani-
mals (that is, activity of a marbling agent in cattle may not translate
to swine). This would limit the market potential of a product.
Alternatives. Genetics and breeding programs could possibly
circumvent or even work in concert with a marbling agent to reli-
ably produce cattle with high levels of marbling (Kim and others
2003; Taniguchi and others 2004; Haley 2006). With the advent of
whole genome selectionmethodology it should soon be possible to
account for a substantial proportion of the genetic variance asso-
ciated with traits such as marbling. This would allow producers to
dramatically increase selection intensity on traits such as marbling
and thereby alter the product produced in subsequent generations.
Whole genome selection strategies to improve traits of interest are
cheaper and easier to implement than drug discovery, approval,
andmarketing. Furthermore, societal concerns associated with the
use of pharmaceutical-based approaches do not apply to the se-
lection of animals for enhanced traits of interest, which indicates
that this approach could be readily accepted by society. Conversely,
breeding programs could lead to the wide use of animals/breeds
that are less responsive to certain treatments, including a marbling
agent. It is already established that, for instance, fat deposition pat-
terns and the adipogenenic process vary across species (Allen 1976;
Allen and others 1976), breeds of cattle (Kim and others 2003), and
even at different sites within an animal (Hood and Allen 1973; Hood
1982). These types of genetic differences, along with differences in
liver enzymes important to the metabolism of a drug, could affect
the pharmacological response to a marbling agent, and add an-
other layer of complexity and challenge to achieving a consistent
response to a marbling agent. Furthermore, whole genome associ-
ation studies should lead to a better understanding of the molecu-
lar mechanisms that control traits of interest. This should, in turn,
generate new targets for pharmaceutical intervention.
Items to double-check. As noted above, economic incentives
for improving growth rate and feed-conversion efficiency have fa-
vored the use of agents and husbandry practices that improve per-
formance, often at the expense of marbling and tenderness. This
trend will likely continue as feedstuffs, especially corn, become
more expensive.
On the side of market acceptance, a broad range of logistical
issues and consumer attitudes could limit the use of a marbling
agent. Novel postharvest technologies designed to improve ten-
derness and flavor might circumvent the need. Although marbling
score is a key parameter used today to value beef, tenderness, fla-
vor, or alternative endpoints, including those potentially incorpo-
rated into “healthy” meat programs, may become more important
in the future. The potential for this change in focus is exemplified
by new marketing programs that target tenderness instead of mar-
bling (Shackelford and others 2001).
There are no policy barriers in the United States that would,
a priori, prevent approval of a promarbling or postmortem ten-
derness product, assuming target animal and human food-safety
requirements are met. However, regional differences in regulatory
environments (and requirements for approval) will persist formany
years. One relevant consequence of this is that performance agents
are not currently approvable in the European Union. This would
likely prevent use of a marbling agent in those regions, and could
restrict beef exports to those regions as well, both adversely af-
fecting the market opportunity. It might be possible to address
this issue by identifying agents that demonstrate health benefits
to the animal in addition to the targeted effect on meat quality.
Improvac
R©
provides an example of this type of dual-action prod-
uct. This immunological agent, directed against GnRF, leads to sup-
pression of testosterone and thereby controls boar taint in male
pigs. Its use circumvents the need for physical castration, allowing
boars to be raised intact, and thus able to realize the health and
performance benefits associated with its own natural androgens
(Dunshea and others 2001). Though it is impossible to predict the
future direction of consumer attitudes toward any agent that enters
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the food chain, it is reasonable to predict that public opinionwill fa-
vor products that improve the health or welfare of the animal over
those that do not.
Conclusions
1. Molecular biology techniques continue to demonstrate thenature and expanding function of the adipocyte. Based on re-
cent history, these approaches and techniques will undoubtedly
identify presently unknown functions of the adipocyte. Genome
markers, probes, genome libraries, promoters, transcription factors
of genes, and other tools for biological research and genetic im-
provement will result in the potential for generating genetically su-
perior animals.
2. The use of molecular biological methods will reveal new in-
sights into the physiology and regulation of marbling and its rela-
tionship to tenderness (quality) of redmeats. Academicsmay argue
the exact correlation, predictability, or shape of the curve, but this
relationship remains at the core of the USDA quality grading sys-
tem, and anyone who has participated in taste panels recognizes
there is some relationship between marbling andmeat tenderness.
Amore specific and detailed understanding of this relationship that
will have direct implications for animal production andmeat qual-
ity is within reach in the future.
3. Adipogenesis/metabolism culture systemswill continue to be
an important screening tool for identifying potential pharmacolog-
ical agents. Beta agonists and PPAR agonists are examples of agents
that alter adipose metabolism and/or proliferation discovered with
in vitro screening, even though PPARγ may not appear to be a good
candidate gene marker for some red meat species. Moreover, other
(mechanistic) knowledge from in vitro work will likely lead to re-
finement of further drug development or applications. Examples of
these are less clear, but in vitro work has played a central role in
the development of omega-3s or DHA as potential feed ingredients
in an attempt to naturally bioengineer red meat to provide healthy
supplements in the form of the right type of fatty acids.
4. The current market opportunity for a red meat marbling
agent justifies investment in research in this area. Several conver-
gent factors in the allied sciences, including advances in livestock
genomics and metabolomics, knowledge around key biological
processes in the bovine adipocyte, and the immense power of high
throughput drug and vaccine screening systems, argue that the
chances for technical success are improving for approaches target-
ing the adipocyte. Adipogenic compounds with the desired profile
in cattle may already be contained within the compound libraries
of pharmaceutical companies. Key challenges to reduce the sci-
ence to useful marbling agents include the lack of knowledge about
molecular targets fully validated in the target animal and poten-
tial issues around target animal and human food safety. Competing
approaches, including advanced breeding techniques and posthar-
vest strategies could circumvent the need for a marbling agent, as
could a major shift in grading emphasis away from marbling (that
is, toward tenderness). However, the potential economic benefits of
a beef marbling agent that targets the adipocyte are probably suffi-
cient to justify the risks posed by competing technologies and po-
tential shifts in the market.
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